GLP-1 300 , 52 , 70%, 1.1 , GLP-1 281.3
Zepbound is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obesity) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease)
BioVendor-Research and Diagnostic Products, Brno, Czech Republic)
However, a rigorous 2024 double-blind pilot trial by Sarkar et al., published in Cureus, tested high-dose EPA and DHA on healthcare workers with Long COVID
Imaeda cautions that this remains a theory